Concepedia

Anna Passarelli

AP

Statistics

Publications

12

Citations

405

H-Index

11

Active since

2010

Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(Current)

University of Bari Aldo Moro

Istituti di Ricovero e Cura a Carattere Scientifico

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Centro di Riferimento Oncologico

Anna Passarelli is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in oncology, medicine, and immunology.

ORCID

Publications per year

2010–2024

12

Publications

12

Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma

Marco Tucci, Anna Passarelli, Francesco Mannavola et al. · OncoImmunology · 2017 · 94 citations · Full text

, , +17

Immune‑related adverse events during anticancer immunotherapy: Pathogenesis and management (Review)

Luigia Stefania Stucci, Raffaele Palmirotta, Anna Passarelli et al. · Oncology Letters · 2017 · 66 citations · Full text

, , +17

Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis

Francesco Mannavola, Marco Tucci, Claudia Felici et al. · Journal of Translational Medicine · 2019 · 55 citations · Full text

, , +17

Alpelisib for PIK3CA-mutated advanced gynecological cancers: First clues of clinical activity

Anna Passarelli, Vittoria Carbone, Sandro Pignata et al. · Gynecologic Oncology · 2024 · 36 citations · Full text

, , +15

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

Sandro Pignata, Daniela Califano, D. Lorusso et al. · Annals of Oncology · 2024 · 35 citations · Full text

, , +12

1–5 of 12